TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 3.50E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 3.50E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair